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ABSTRACT
Oxidative stress is implicated in the development of non-alcoholic steatohepatitis (NASH). The Nrf2-antioxidant response
element pathway protects cells from oxidative stress. Studies have shown that global Nrf2 deficiency hastens the
progression of NASH. The purpose of this study was to determine whether long-term hepatocyte-specific activation of Nrf2
mitigates NASH progression. Transgenic mice expressing a constitutively active Nrf2 construct in hepatocytes (AlbCreþ/
caNrf2þ) and littermate controls were generated. These mice were fed standard or methionine-choline-deficient (MCD) diet,
a diet used to induce NASH development in rodents. After 28 days of MCD dietary feeding, mice developed significant
increases in steatosis, inflammation, oxidative stress, and HSC activation compared with those mice on standard diet.
AlbCreþ/caNrf2þ animals had significantly decreased serum transaminases and reduced steatosis when compared with
the AlbCreþ/caNrf2 animals. This significant reduction in steatosis was associated with increased expression of genes
involved in triglyceride export (MTTP) and b-oxidation (CPT2). However, there were no differences in the increased oxidative
stress, inflammation, and HSC activation from MCD diet administration between the AlbCreþ/caNrf2 and AlbCreþ/
caNrf2þ animals. We conclude that hepatocyte-specific activation of Nrf2-mediated gene expression decreased
hepatocellular damage and steatosis in a dietary model of NASH. However, hepatocyte-specific induction of Nrf2-mediated
gene expression alone is insufficient to mitigate inflammation, oxidative stress, and HSC activation in this nutritional NASH
model.
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Obesity is one of the major health epidemics facing the world
today. More than one-third of the U.S. adult population is con-
sidered obese with body mass index greater than 30 kg/m2
(Flegal et al., 2012). In the liver, obesity leads to non-alcoholic
fatty liver disease (NAFLD) and non-alcoholic steatohepatitis
(NASH). The prevalence of NAFLD has been estimated to be
between 15% and 50%, and approximately 30% of patients with
NAFLD will eventually progress into NASH (Adams and Lindor,
2007; Farrell and Larter, 2006).
Although NAFLD and NASH have been recognized as two of
the most common liver disorders, their pathogenesis is complex
and remains to be elucidated. The current thought regarding
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the development of NAFLD and NASH involves the “two-hit” hy-
pothesis. With caloric excess, there is increased adiposity, insu-
lin resistance, and development of hepatic steatosis, or NAFLD.
This eventually leads to increased lipotoxic metabolites and in-
creased b-oxidation, which results in increased oxidative stress
and lipid peroxidation. These processes lead to a second hit, re-
sulting in inflammation and the development of NASH (Rolo
et al., 2012). There is currently no standard therapy to decrease
the progression of NAFLD to NASH and cirrhosis.
Nuclear factor (erythroid-derived 2)-like 2 (Nrf2) is a basic
leucine zipper transcription factor with a Cap “n” Collar struc-
ture that is key to the cellular antioxidative response. Nrf2 is
normally bound in the cytoplasm to the Keap1 protein via the
Neh2 domain on the N-terminal of Nrf2. Keap1 acts as a nega-
tive regulator of Nrf2 by targeting Nrf2 toward ubiquitination
and degradation (Zhang and Hannink, 2003). The presence of
oxidative stress leads to modification of Keap1’s cysteine thiols,
resulting in the weakening of the Nrf2-Keap1 interaction, which
allows newly synthesized Nrf2 to be translocated into the nu-
cleus (Wakabayashi et al., 2004). Once in the nucleus, Nrf2 binds
the antioxidant response element (ARE), and initiates the tran-
scription and translation of several antioxidative and other
cytoprotective genes (Lee et al., 2003).
Previous experiments have demonstrated that the global ab-
sence of Nrf2 leads to exacerbated development of NASH in a di-
etary-induced murine model of NASH (Chowdhry et al., 2010;
Sugimoto et al., 2010; Tanaka et al., 2008). In addition, globally
enhanced expression of Nrf2 leads to a reduction in the onset of
fatty liver disease in mice fed a methionine and choline defi-
cient (MCD) diet (Zhang et al., 2010). However, less is known re-
garding the effect of cell-specific Nrf2 overexpression in NASH
development. Given that hepatocyte are primarily responsible
for lipid metabolism and detoxification, we wanted to deter-
mine whether induction of the Nrf2-ARE pathway selectively in
hepatocytes would mitigate NASH development similarly to
that seen in the other published studies that utilized mice with
global Nrf2 overexpression.
To achieve this aim, we used transgenic mice expressing a
constitutively active Nrf2 (caNrf2) mutant that lacks the N-ter-
minal Neh2 domain under control of a ubiquitously active b-ac-
tin promoter and a CMV enhancer (Schafer et al., 2012). Due to
the lack of the Keap1-binding domain, caNrf2 is stabilized and
continuously translocates to the nucleus, resulting in overex-
pression of Nrf2 target genes. Upon mating these mice with
transgenic mice expressing Cre under the control of the hepato-
cyte-specific albumin promoter (AlbCre), we obtained mice with
hepatocyte-specific overactivation of the Nrf2-ARE pathway
(Kohler et al., 2014).
The MCD diet was used to establish NASH in our murine
model. The MCD diet is a well-established experimental model
of NASH development in rodents. It rapidly generates the clini-
cal histologic features of NASH, including steatosis, ballooning
degeneration, focal inflammation, hepatic necrosis, and fibrosis
(Rinella et al., 2008). The pathological features of NASH may be
seen in as short as 2–5 days of diet (Zhang et al., 2010). The
mechanism for which MCD is thought to lead to NASH develop-
ment is partly due to choline deficiency. This leads to decreased
generation of phosphatidylcholine, which is required for gener-
ation of very low-density lipoprotein (VLDL) for triglyceride ex-
port from the liver. Methionine deficiency also leads to
decreased generation of S-adenosylmethionine and glutathi-
one, which results in increased oxidative stress and inflamma-
tion, and simulates the second hit of the “two-hit” hypothesis
(Caballero et al., 2010; Rinella et al., 2008).
The objectives of this study were to determine whether
long-term, cell-specific activation of the Nrf2-ARE pathway in
hepatocytes could decelerate the progression of NASH. More
specifically, we assessed whether this hepatocellular expres-
sion of caNrf2 leads to a reduction in steatosis, oxidative stress,
inflammation, and hepatic stellate cell activation in mice sub-
jected to nutritionally induced NASH.
MATERIALS ANDMETHODS
Animals. Mice expressing a constitutively active Nrf2 (caNrf2)
under the control of a CMV promoter and b-actin enhancer
(Schafer et al., 2012) in hepatocytes postnatally have previously
been described (Kohler et al., 2014). To avoid constitutive expres-
sion of the transgene in all cells, the caNrf2 cDNA is preceded by
a floxed transcription/translation STOP cassette. Upon mating
of these mice with transgenic mice expressing Cre in hepato-
cytes under control of the albumin promoter (AlbCre mice)
(Jackson Labs, Bar Harbor, Maine), the STOP cassette is excised
and caNrf2 is expressed. The transgenic mice were shown to
express the caNrf2 protein at similar levels as the endogenous
protein in the liver (Kohler et al., 2014). Since the caNrf2 protein
is constitutively present in the nucleus, it efficiently induces
expression of Nrf2 target genes, resulting in their upregulation.
Importantly, levels of caNrf2 and endogenous Nrf2 protein were
similar in the livers of these mice, indicating that the induction
of Nrf2 target gene expression by the transgene is comparable
to the induction seen upon pharmacological activation of the
endogenous protein (Kohler et al., 2014).
Transgenic mice (age 6–8 weeks) with hepatocyte-specific
expression of caNrf2 (AlbCreþ/caNrf2þ) and littermate controls
(AlbCreþ/caNrf2) were fed either standard chow (8604 Teklad
Rodent Diet; Harlan Teklad, Madison, Wisconsin) or MCD diet
(Cat No. 0296043910; MP Biomedical, Solon, Ohio). Among the
AlbCreþ/caNrf2 mice, 6 were fed standard chow and 7 were
fed the MCD diet. Among the AlbCreþ/caNrf2þ mice, 7 were fed
standard chow and 8 were fed the MCD diet. All mice had access
to diet and water ad libitum. After 28 days of diet, livers and
serum were obtained for analyses. All experiments were per-
formed according to the ethical guidelines outlined in the Guide
for Care and Use of Laboratory Animals and approved by the
Animal Care and Use Committee at the University of Wisconsin
School of Medicine and Public Health.
Histology. The murine livers were flushed with PBS at the time of
sacrifice. Fresh liver specimens were then divided equally; snap
freezing a portion in O.C.T for subsequent lipid staining, and the
remaining tissue fixed in 10% neutral buffered formalin for fur-
ther processing into paraffin blocks.
Oil Red O staining. Frozen mouse liver specimens were sectioned
at a thickness of 5 m, fixed with 10% neutral buffered formalin
for 5 min and subsequently stained for lipid deposition. Lipids
were detected using an Oil Red O (ORO) stain, consisting of 1 g
ORO dye dissolved in 100 ml 70% EtOH/acetone mixture.
Sections underwent an acclimation rinse in 70% EtOH, followed
by 10 min incubation in working ORO solution. The sections
were then differentiated in 70% EtOH before being counter-
stained with hematoxylin for contrast.
Immunohistochemistry. Paraffin-embedded mouse livers were
sectioned at a thickness of 5 m and either stained with routine
Hematoxylin and eosin (H&E) or immunohistochemistry was
performed using rabbit anti-a-SMA (Epitomics, Burlingame,
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California) or rabbit anti-F4/80 (eBioscience, San Diego,
California) primary antibodies. For a-SMA staining, tissue sec-
tions underwent antigen retrieval using citrate buffer pH 6.0 in
a decloaking chamber (Biocare Medical, Concord, California),
followed by incubation with anti-a-SMA (1:8000) for 1 h at room
temperature. For F4/80, enzyme-induced epitope retrieval using
proteinase K was performed for 5 min at room temperature,
followed by incubation with anti-F4/80 (1:40) for 1 h at room
temperature. For both, antibody detection was conducted using
ImmPRESS anti-rabbit Ig HRP (Vector Labs, Burlingame,
California), the signal visualized with DAB, and sections coun-
terstained with hematoxylin for contrast.
For a-CD3 and a-Ly6G immunohistochemistry, the sections
were initially incubated in 12% bovine serum albumin in phos-
phate-buffered saline (PBS)/0.025% NP40 for 1 h for blocking.
The sections were then incubated overnight at 4C with primary
antibodies a-Ly6G (BD Biosciences) and a-CD3 (DAKO) diluted in
blocking solution. After washing in PBS, sections were stained
using the ABC Vectastain Peroxidase Kit and the AEC Peroxidase
Substrate Kit (Vector Laboratories) as described by the manufac-
turer. Sections were counterstained with hematoxylin and
mounted with Mowiol.
Image analysis. The slides for each animal were visualized under
light microscopy using Axiovert 200M microscope (Carl Zeiss,
Gottingen, Germany). Four random high-powered fields of view
were taken for each animal.
Serum analysis. Whole blood was collected at the time of sacri-
fice. Blood was allowed to coagulate at room temperature for at
least 30 min and then spun down to collect the serum. Serum
ALT and AST were measured using the IDEXX VetTest
Chemistry Analyzer (IDEXX, Westbrook, Maine). Serum trigly-
ceride content was measured using Wako L-Type TG M Assay
kit (Wako Chemicals USA, Richmond, Virginia) following the
protocol provided in the kit.
Tissue triglyceride. Liver tissue triglyceride was extracted using
the Folch method (Folch et al., 1957). Briefly, approximately
25 mg of liver was homogenized in a 2:1 chloroform:methanol
mixture. Water was then added to the mixture and phase
extraction performed. The organic layer was isolated and sub-
jected to speed vacuum. The resulting pellet was then resus-
pended in isopropanol. The triglyceride content was
determined using Wako L-Type TG M Assay kit (Wako
Chemicals USA) and the protocol provided in the kit.
Triglyceride content was normalized to the weight of the liver
tissue used.
Thiobarbituric acid reactive substances. Thiobarbituric acid reactive
substances (TBARS) in the liver tissue were determined via com-
mercially available TBARS Assay kit (Cayman, Ann Arbor,
Michigan). Briefly, approximately 25 mg of liver was homogen-
ized in radioimmunoprecipitation assay (RIPA) buffer supple-
mented with protease inhibitor. The resulting supernatant was
then used for the assay following the protocol provided in the
kit. Fluorescence for the samples was read at an excitation
wavelength of 530 nm and an emission wavelength of 550 nm
using SpectraMax M2 Microplate Reader (Molecular Devices,
Sunnyvale, California). TBARS content was normalized to the
weight of the liver tissue used.
8-Isoprostane. The hepatic 8-isoprostane levels were determined
using the 8-Isoprostane EIA kit (Cayman) and the protocol
provided in the kit. Briefly, approximately 100 mg of liver tissue
from each animal was homogenized in 0.1 M phosphate, 1 mM
EDTA, and 0.005% butylated hydroxytoluene (BHT), pH 7.4 solu-
tion. Total 8-isoprostane was obtained by adding 1 vol of 15%
KOH to each of the sample, incubated at 40C for 60 min, fol-
lowed by neutralization using 3 vol of 1 M potassium phosphate
buffer, pH 7.4. Fifty microliter of each sample was used for the
assay in duplicates. 8-Isoprostane AChE tracer was then added
to the sample wells and allowed to incubate overnight at 4C.
After rinsing with Wash Buffer 5 times, Ellman’s Reagent was
added to the wells, and the reaction mixture was allowed to
develop at room temperature for 90 min. Absorbance at 412 nm
was then read using SpectraMax M2 Microplate Reader
(Molecular Devices). 8-Isoprostane levels were normalized to
the weight of the liver tissue used.
Quantitative RT–PCR. A small piece of liver tissue was initially
stored in RNAlater (Life Technologies, Carlsbad, California)
at the time of sacrifice. RNA was subsequently extracted using
TRIzol Reagent (Life Technologies) per commercial protocol.
RNA quality and quantity was assessed on an Agilent 2100
Bioanalyzer. Samples with RNA integrity number greater
than 8.0 were used in subsequent studies. Synthesis single-
stranded cDNA was performed using the Promega Reverse
Transcription System (Promega, Madison, Wisconsin).
Quantitative RT-PCR was then performed using the Bullseye
EvaGreen qPCR mix (MidSci, St Louis, Missouri) in Roche
LightCycler 480 (Roche Diagnostics, Mannheim, Germany). The
primer sequences used are listed in the Supplementary
Material.
Western blot analysis. Three random animals from each experi-
mental group were used for western analysis. Whole-cell pro-
tein was obtained from frozen liver tissue homogenized in RIPA
buffer. Protein concentration was determined via BCA protein
Assay (Thermo Scientific Pierce, Rockford, IL). Ten micrograms
of protein was denatured in Laemmli loading buffer at 95C for
5 min. The samples were then loaded on 12% acrylamide gels.
Gels were transferred to PVDF membranes and probed over-
night with anti-NQO1 (Epitomics), anti-GCLM (provided by Dr
Terry Kavanagh, University of Washington, Seattle, WA), anti-
GstA2, anti-MTTP (Abcam), anti a-SMA (Abcam), or anti-b-actin
(Abcam) antibodies. Blots were probed with anti-rabbit HRP or
anti-mouse HRP (KPL, Gaithersburg, Maryland) as appropriate
for 1 h and developed with Pierce ECL Western Blotting
Substrate (Thermo Scientific Pierce). Densitometry for bands of
interest was performed using ImageJ (Rasband, 1997–2012).
Statistics. All data in figures are presented as mean6SEM.
Comparisons between the groups were performed with one-
way ANOVA followed by Fisher’s LSD post hoc test, unless stated
otherwise in the figure legends. Log transformation was per-
formed as appropriate as determined by Levene’s test for equal-
ity of variance. P< 0.05 was used for statistical significance. All
statistical tests were performed using IBM SPSS Statistics ver-
sion 21.
RESULTS
AlbCre1/caNrf21Mice Show Enhanced Nrf2-Dependent Gene and
Protein Expression When Compared With Control Mice
Transgenic mice with hepatocyte-specific Nrf2 overactivation
(AlbCreþ/caNrf2þ) and their littermate controls without the
constitutively active Nrf2 construct (AlbCreþ/caNrf2) were fed
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a standard chow or MCD diet for 28 days. Six AlbCreþ/caNrf2
mice received standard chow, and 7 AlbCreþ/caNrf2 mice
received MCD diet. Seven AlbCreþ/caNrf2þ mice received
standard chow, and 8 AlbCreþ/caNrf2þ mice received MCD diet.
Unless stated otherwise, all subsequent analyses were per-
formed on these groups of animals.
To confirm that the AlbCreþ/caNrf2þ mice had increased
activity of Nrf2 at baseline compared with littermate controls,
we examined the expression of Nrf2-dependent genes in the liv-
ers of the AlbCreþ/caNrf2þ mice. RNA was isolated from the
liver of the experimental animals, and qRT-PCR was performed
for the prototypical Nrf2-dependent genes. The results are listed
in Table 1. Baseline mRNA abundance of GSTM1, GSTA2, GSTA4,
and NQO1 were significantly higher in AlbCreþ/caNrf2þ ani-
mals on standard diet when compared with littermate controls,
consistent with previously reported data (Kohler et al., 2014).
The greatest increases were seen with NQO1 (11.4-fold) and
GSTA2 (13.0-fold), while there was an approximate 50% decrease
in GCLM message at baseline in the AlbCreþ/caNrf2þ animals.
Among the animals receiving MCD diet, there were significant
increases in all of the Nrf2-dependent genes tested in the
AlbCreþ/caNrf2þ animals when compared with their littermate
controls. When AlbCreþ/caNrf2 animals were fed an MCD
diet, there were significant increases in GSTA2 (2.56-fold) and
NQO1 (2.06-fold). In comparison, for AlbCreþ/caNrf2þ animals
fed a MCD diet, there were significant increases in all of the pro-
totypical Nrf2-dependent genes.
We then used 3 random animals from each experimental
group for Western blot to determine the protein expression of
the prototypical Nrf2-dependent genes (Fig. 1). At baseline with
standard chow, there were significant increases in GCLM,
GstA2, and Nqo1 in AlbCreþ/caNrf2þ animals when compared
with controls. This increase in GCLM protein was seen in spite
of the lower abundance of GCLM mRNA. When AlbCreþ/
caNrf2 animals were fed MCD diet compared with standard
chow, there was significant increase in Nqo1 protein, and no
significant changes in GCLM and GstA2. For the AlbCreþ/
caNrf2þ animals, MCD feeding resulted in significant increases
in GCLM, GstA2, and Nqo1 protein when compared with stand-
ard chow. Among the animals receiving a MCD diet, there were
significant increases in GCLM, GstA2, and Nqo1 in the AlbCreþ/
caNrf2þ animals compared with littermate controls. Taken
together, the mRNA and protein data suggest that there are
increases in several Nrf2-dependent proteins in the AlbCreþ/
caNrf2þ animals at baseline without any stress stimulus.
Independent of the mouse genotype, the MCD diet activates the
Nrf2-ARE pathway, resulting in increased expression of some
Nrf2-dependent proteins. However, in the AlbCreþ/caNrf2þ ani-
mals, MCD feeding leads to further augmentation of Nrf2-
dependent gene and protein expression when compared with
their littermate controls.
Constitutive Activation of Nrf2 in Hepatocytes Decreases
Hepatocellular Damage from MCD Diet
The transgenic mice were fed 28 days of standard chow versus
MCD diet. Blood serum was collected at the time of sacrifice,
and serum ALT and AST were measured to assess for clinical
evidence of hepatocellular damage. After 28 days of MCD diet,
TABLE 1. Nrf2-Dependent Gene Expression
Genes AlbCre1/caNrf2- AlbCre1/caNrf21 Dietary Effect Genetic Effect
Std Chow MCD Std Chow MCD AlbCre1/caNrf2- AlbCre1/caNrf21 Std Chow MCD
Columns 1 2 3 4 1 versus 2 3 versus 4 1 versus 3 2 versus 4
GCLC 1.006 0.08 0.556 0.11* 1.3560.23 3.6760.31*, ** 0.55 2.72 — 6.66
GCLM 1.006 0.10 0.486 0.07* 0.5260.08** 0.9660.09*, ** 0.48 1.85 0.52 1.97
GSTM1 1.006 0.11 0.696 0.08 3.6861.47** 7.3861.72*, ** — 3.26 2.26 10.7
GSTA2 1.006 0.21 2.566 0.36* 13.063.87** 32.764.93*, ** 2.56 2.51 13.0 12.8
GSTA4 1.006 0.16 1.326 0.14 1.8960.16** 3.3860.45*, ** — 1.79 1.89 2.57
NQO1 1.006 0.08 2.066 0.22* 11.461.95** 21.362.91*, ** 2.06 1.87 11.4 10.3
RNA was isolated from the collected liver sample, and qRT-PCR was performed for the prototypical Nrf2-dependent genes. The mRNA levels are first normalized to the
b-actin mRNA content of each sample, then each group is normalized to the AlbCreþ/caNrf2, standard chow group. All data are presented as mean6SEM. N¼6–8 for
each of the 4 groups. The fold changes in mRNA abundance were compared between groups using one-way ANOVA with Fisher’s LSD post hoc test. Significant fold
changes are presented on the right side of the table. *P<0.05 when compared with standard chow of the same genotype. **P<0.05 when compared with AlbCreþ/
caNrf2 on the same diet.
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FIG. 1. Western blot analysis of Nrf2 target proteins. A, After 28 days of diet,
Western blot of 3 random animals from each experimental group was per-
formed for the prototypical Nrf2-dependent proteins: GCLM, GstA2, and Nqo1. B,
Densitometry of the presented blot demonstrated significant increases in the
examined Nrf2-dependent proteins in the AlbCreþ/caNrf2þ animal when com-
pared with AlbCreþ/caNrf2 animals independent of diet. *P<0.05 when com-
pared with standard chow of the same genotype. #P<0.05 when compared with
AlbCreþ/caNrf2 on the same diet.
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AlbCreþ/caNrf2 and AlbCreþ/caNrf2þ mice had significantly
elevated serum transaminases when compared with those on
standard chow. However, AlbCreþ/caNrf2þ mice had an
approximate 40% decrease in serum transaminase levels when
compared with AlbCreþ/caNrf2 mice on MCD diet, which was
statistically significant (Fig. 2). This suggests that constitutive
activation of Nrf2 in hepatocytes alone offers hepatocellular
protection from the stress of MCD diet.
Constitutive Activation of Nrf2 in Hepatocytes Leads to Decreased
Hepatic Lipid Accumulation from MCD Diet
To further investigate the effect of constitutive activation of the
Nrf2-ARE pathway on the development of steatosis, we per-
formed histologic analyses on the liver tissue. H&E staining
revealed normal appearing livers in mice receiving standard
chow. We saw increased steatosis and inflammatory infiltration
in the animals receiving MCD diet when compared with the
standard chow animals. However, among the animals receiving
MCD diet, marked increase in steatosis was seen in the livers of
AlbCreþ/caNrf2 mice (Fig. 3). There was a marked decrease in
the percentage of hepatocytes with macrosteatosis in the
AlbCreþ/caNrf2þ animals on MCD diet in comparison. This pro-
tection against steatosis is seen most prominently around zone
3 on histology.
We then performed ORO staining to better characterize the
extent of lipid deposition (Fig. 4). Although animals on standard
chow have minimal lipid staining, there was increased lipid
staining for animals on MCD diet. Among the animals receiving
MCD diet, even though there was a range in the amount of stea-
tosis present, there was in general a decrease in the amount of
lipid staining in the livers from AlbCreþ/caNrf2þ mice when
compared with AlbCreþ/caNrf2 animals.
To quantify the amount of lipid deposition in the liver, we
measured the amount of hepatic tissue triglyceride biochemi-
cally. Animals on MCD diet had significantly increased tissue
triglyceride when compared with animals on standard chow.
There was a significant, 35% reduction of hepatic tissue trigly-
ceride in the AlbCreþ/caNrf2þ animals when compared with lit-
termate controls (Fig. 4G). We also measured the amount of
serum triglyceride at the time of sacrifice. There were no
significant differences in serum triglyceride levels among all 4
groups of animals (Fig. 4H).
Constitutive Activation of Nrf2 in Hepatocytes Alone Leads to
Changes in the Expression Profile of Lipid Metabolism Genes When
Fed a MCD Diet
To better understand the mechanisms underlying the effect of
Nrf2-ARE activation on steatosis, we investigated the mRNA
profiles of several lipid metabolism-related genes. Using RNA
isolated from the animals’ liver samples, we performed qRT-
PCR of lipid metabolic genes, and these results are presented in
Table 2. At baseline with standard chow, there was a decrease
in CPT1A mRNA in AlbCreþ/caNrf2 animals. When fed a MCD
diet, both groups of mice responded with significant decreases
in almost all of the lipid metabolism genes tested. However,
among the animals on MCD diet, AlbCreþ/caNrf2þ mice dem-
onstrated increased CPT2 and MTTP when compared with the
AlbCreþ/caNrf2 animals. There were no significant changes in
mRNA abundance of the major lipid metabolic genes.
Western blot of MTTP was performed using three random
animals from each experimental group. Although MTTP protein
level did not appear to change based on diet, there was signifi-
cantly increased MTTP protein in AlbCreþ/caNrf2þ animals
when compared with the littermate controls independent of the
diet given (Fig. 5).
Constitutive Activation of Nrf2 in Hepatocytes Alone Does Not Affect
Hepatic Inflammation Resulting from MCD Diet
To more specifically look at inflammation, we first performed
immunohistochemistry using F4/80 antibody on the liver tissue
to detect the number of macrophages in each of the 4 groups of
mice. Feeding the MCD diet led to significant increase in the
number of infiltrating macrophages when compared with
standard chow. However, among the animals fed a MCD diet,
there was no difference in the number of macrophages in the
AlbCreþ/caNrf2þ mice when compared with the AlbCreþ/
caNrf2 mice (Fig. 6).
Quantitative RT-PCR was also performed for proinflamma-
tory genes, including IL1B, IL6, IL12B, TNF, ICAM1, CCL2, and
CXCL10. We did not see changes in the mRNA abundance in the
majority of the proinflammatory genes (Table 3). MCD diet did
lead to significant increases in CCL2 gene transcript levels com-
pared with standard chow. However, there was no significant
difference in CCL2 mRNA abundance in AlbCreþ/caNrf2þ mice
versus AlbCreþ/caNrf2 mice fed MCD diet.
Constitutive Activation of Nrf2 in Hepatocytes Alone Does Not Affect
Oxidative Stress from MCD Diet
Seeing that Nrf2 overactivation in hepatocytes led to a reduc-
tion in steatosis with MCD diet, we decided to examine its
impact on hepatic oxidative stress. We measured the amount of
TBARS in the livers among the different groups of mice. TBARS
is formed as a byproduct of lipid peroxidation, and it is routinely
measured as a marker of oxidative stress (Armstrong and
Browne, 1994). The amount of TBARS was significantly elevated
in mice receiving MCD diet versus standard chow. However,
there was no difference in TBARS in the AlbCreþ/caNrf2þ mice
when compared with AlbCreþ/caNrf2 mice receiving MCD diet
(Fig. 7A).
We also measured the levels of 8-isoprostane as another
marker of lipid peroxidation and oxidative stress (Morrow and
Roberts, 1996). All mice receiving MCD diet demonstrated signif-
icantly increased hepatic levels of 8-isoprostane when com-
pared with those receiving standard chow. However, there was
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FIG. 2. Serum ALT and AST. Serum was collected from AlbCreþ/caNrf2þ and
AlbCreþ/caNrf2 animals at the end of 28 days of diet, and serum transami-
nases were measured. Animals on MCD diet have significantly elevated serum
transaminases compared with animals on standard chow for both genotypes.
However, AlbCreþ/caNrf2þ animals have significantly decreased serum transa-
minases when compared with the AlbCreþ/caNrf2 animals on MCD. N¼ 6–8
for each of the four groups. *P<0.05 when compared with standard chow of the
same genotype. #P<0.05 when compared with AlbCreþ/caNrf2 on the same
diet.
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no difference in 8-isoprostane level in the AlbCreþ/caNrf2þ
mice compared with AlbCreþ/caNrf2 mice receiving MCD diet
(Fig. 7B).
Constitutive Activation of Nrf2 in Hepatocytes Alone Does Not Affect
Stellate Cell Activation in Response to MCD Diet
Hepatic stellate cell (HSC) activation is a well-described process
contributing to the generation of fibrosis in NASH. We investi-
gated the impact of Nrf2 overexpression in hepatocytes on the
degree of HSC activation in this dietary model of NASH. To
assess HSC activation, we performed qRT-PCR on fibrogenic
genes, including COL1A1, TIMP1, TIMP2, MMP2, and MMP9. We
did not see significant changes in most of the fibrogenic genes
with feeding MCD diet for 28 days. There was significant
increase in TIMP1 mRNA abundance with MCD diet feeding in
both groups of transgenic mice when compared with standard
chow. However, there was no difference in mRNA abundance of
TIMP1 in the AlbCreþ/caNrf2þ mice when compared with
AlbCreþ/caNrf2 mice receiving MCD diet (Table 4).
Immunohistochemistry for a-SMA was also performed to
determine the extent of HSC activation (Fig. 8). There was
increased a-SMA staining in the livers of animals fed an MCD
diet compared with control diet. However, there was no differ-
ence in HSC activation between the AlbCreþ/caNrf2þ and
AlbCreþ/caNrf2 animals on MCD diet. Western blot was then
performed to determine the amount of a-SMA protein. Three
random animals from each experimental group were used for
protein analysis. Although there was significantly increased
level of a-SMA protein in the animals fed an MCD diet when
compared with the standard chow animals, there was no
significant difference between the AlbCreþ/caNrf2þ and
AlbCreþ/caNrf2 animals on MCD diet (Figs. 8E and 8F).
Constitutive Activation of Nrf2 in Hepatocytes Alone Does Not Affect
Liver Homeostasis in Young and Aged Mice
In addition to feeding our transgenic animals with MCD diet, we
also looked at the effect of the transgenes themselves on the
animal livers beyond their experimental age. Four to five ani-
mals in each of the AlbCreþ/caNrf2 and AlbCreþ/caNrf2þ
group were aged up to 18 months old on standard chow. They
were then sacrificed and their livers examined. The results are
shown in Supplementary Data.
By 12 months of age, there was no significant difference in
the liver-to-body weight ratio between the two genotypes. ORO
was performed on the animals’ livers. Although there appeared
to be some ORO staining demonstrating development of steato-
sis due to aging, there was no difference between the genotypes.
There was also no significant difference in hepatic inflamma-
tion as determined by immunohistochemistry using a-CD3 and
a-Ly6G. Blood serum was also collected at 48- and 72-weeks of
age, which demonstrated no significant differences in serum
glucose and LDL-cholesterol levels, suggesting no difference in
hepatic metabolism.
DISCUSSION
The Nrf2-ARE pathway is an endogenous antioxidant pathway
that provides cellular defense from oxidative damage. NAFLD
and NASH are pathologies with increasing relevance due to the
obesity epidemic. Although oxidative stress has been implicated
50μm
50μm 50μm
50μm
A B
C D
FIG. 3. Representative hematoxylin and eosin stain of the livers after 28 days diet. Both A, AlbCreþ/caNrf2 and B, AlbCreþ/caNrf2þ animals on standard chow demon-
strated normal liver histology. When fed an MCD diet, C, AlbCreþ/caNrf2 animals exhibited widespread macrosteatosis, whereas D, AlbCreþ/caNrf2þ animals dem-
onstrated less steatosis in comparison. The area of protection against steatosis in AlbCreþ/caNrf2þ animals appeared most prominently around zone 3.
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FIG. 4. Liver lipid deposition. Oil Red O staining was performed on the liver tissue at the end of the diet. AlbCreþ/caNrf2 (A) and AlbCreþ/caNrf2þ (B) animals on
standard diet demonstrated minimal lipid staining. MCD diet increased lipid deposition in the livers. C, and E, demonstrate the range of lipid deposition in the
AlbCreþ/caNrf2 animals on MCD diet. D, and F, demonstrate the range of lipid deposition in the AlbCreþ/caNrf2þ animals on MCD diet. In general, there was more
lipid staining in the AlbCreþ/caNrf2 animals on MCD diet when compared with the AlbCreþ/caNrf2þ animals. G, Triglyceride was extracted from the liver tissue and
its amount determined. MCD diet led to increased tissue triglyceride for both AlbCreþ/caNrf2 and AlbCreþ/caNrf2þ animals. However, the amount of triglyceride in
AlbCreþ/caNrf2þ animals on MCD is significantly decreased when compared with the AlbCreþ/caNrf2 animals. This confirms the histological findings. H, Serum tri-
glyceride level was obtained at the time of sacrifice. There were no differences in the serum triglyceride levels among the animals. N¼6–8 for each of the 4 groups.
*P<0.05 when compared with standard chow of the same genotype. #P< 0.05 when compared with AlbCreþ/caNrf2 on the same diet.
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in the development of NASH from NAFLD, little is known
regarding the cell-specific effects of the Nrf2-ARE pathway on
the development of NAFLD and NASH. To the best of our knowl-
edge, this is the first study that has investigated the effect of
hepatocyte-specific activation of the Nrf2-ARE pathway in the
development of dietary-induced NASH. Here, we show that
selective expression of caNrf2 in hepatocytes leads to decreased
steatosis in mice fed a MCD diet. However, despite this signifi-
cant reduction on steatosis, the chronic, cell-specific activation
of Nrf2-mediated gene expression in hepatocytes did not lead to
a reduction in the other characteristics of NASH development,
including inflammation, oxidative stress, and fibrogenesis.
In this study, we used the MCD diet model to assess the
impact of cell-specific Nrf2 activation on liver pathology most
commonly seen in human NASH. We recognize that the MCD
diet is not a true representation of the clinical situation whereby
patients develop NASH in the settings of obesity, insulin resist-
ance, and metabolic syndrome. We chose this diet because the
pathologic manifestations of clinical NASH, including steatosis,
ballooning degeneration, inflammation, and fibrosis, are all
present in the livers of mice receiving the MCD diet (Larter and
Yeh, 2008). Numerous groups have studied the effects of sys-
temic Nrf2 deficiency on the development of NASH using a vari-
ety of steatosis inducing diets, including high fat diet (HFD),
MCD diet, or even an atherogenic plus HFD. In all these studies,
independent of the diets utilized, the absence of Nrf2 led to
increased steatosis and oxidative stress (Chowdhry et al., 2010;
Okada et al., 2013; Sugimoto et al., 2010; Tanaka et al., 2008, 2012).
However, published studies using models of Nrf2 overactiva-
tion revealed a more heterogeneous view on Nrf2’s effect on
hepatic steatosis. In these studies, systemic Nrf2 overactivation
was achieved with a genetic Keap1-knock down (K1kd) model or
through pharmacologic induction with CDDO-Im. Studies from
Shin et al. (2009) using CDDO-Im with HFD for up to 95 days and
Zhang et al. (2010) using K1kd mice with MCD diet for 5 days,
both demonstrated attenuation of NASH development.
However, Xu et al. (2012) using leptin-deficient (Lepob/ob) K1kd
mice up to 16 weeks of age and More et al. (2013) using K1kd
mice with HFD for 24 weeks, both demonstrated increased hep-
atic steatosis with Nrf2 overactivation. Although our reduction
in steatosis corresponds with the former results, the contradic-
tory result with the latter remains difficult to reconcile. One
noticeable difference is that in the studies demonstrating a pro-
tective effect of Nrf2, the diets were used for a relative short
term, up to 4 weeks. However, More et al. used 24 weeks of diet,
and Xu et al. used 16 week old Lepob/ob mice that likely began
obesity development early in life during preweaning (Friedman
and Halaas, 1998; Thurlby and Trayhurn, 1978). In fact, Xu et al.
noted in their study that there was no difference in hepatic
steatosis between Lepob/ob and Lepob/ob K1kd at 8 weeks of age.
They also noted that K1kd inhibited lipid accumulation in Lepob/
ob skeletal muscle at 8 weeks of age, but promoted lipid accumu-
lation by 16 weeks of age. Therefore, it is possible that the pro-
tection of Nrf2 on hepatic steatosis may be a time limited effect.
TABLE 2. Expression of Genes Associated with Lipid Metabolism
Genes AlbCreþ/caNrf2 AlbCreþ/caNrf2þ Dietary Effect Genetic Effect
Std Chow MCD Std Chow MCD AlbCreþ/caNrf2- AlbCreþ/caNrf2þ Std Chow MCD
Columns 1 2 3 4 1 versus 2 3 versus 4 1 versus 3 2 versus 4
Master regulators
LXR 1.0060.05 0.8860.16 0.906 0.15 0.926 0.17 — — — —
SREBF1 1.0060.14 0.5060.07* 1.296 0.24 0.546 0.07* 0.50 0.41 — —
PPARa 1.0060.09 0.4960.08* 0.856 0.18 0.446 0.09* 0.49 0.52 — —
PPARc 1.0060.06 1.3260.21 1.356 0.29 2.226 0.39 — — — —
b-Oxidation
ACOX1 1.0060.11 0.3360.05* 0.826 0.12 0.356 0.04* 0.33 0.43 — —
CPT1A 1.0060.12 0.4160.02* 0.686 0.06** 0.526 0.06* 0.41 0.76 0.68 —
CPT2 1.0060.06 0.4660.03* 0.946 0.08 0.776 0.05*, ** 0.46 0.81 — 1.66
Triglyceride export
MTTP 1.0060.17 0.3860.04* 1.006 0.15 0.616 0.07*, ** 0.38 0.61 — 1.62
APOB 1.0060.05 0.7060.06* 1.056 0.09 0.856 0.06* 0.70 0.80 — —
qRT-PCR was performed for lipid metabolism genes of AlbCreþ/caNrf2 versus AlbCreþ/caNrf2þ animals on MCD diet after 28 days. The mRNA levels are first normal-
ized to the b-actin mRNA content of each sample, and each experimental group is then normalized to the AlbCreþ/caNrf2, standard chow group. All data are pre-
sented as mean6SEM. N¼6–8 for each of the 4 groups. The fold changes in message abundance were compared between groups using one-way ANOVA with Fisher’s
LSD post hoc test. Significant fold changes are presented on the right side of the table. *P<0.05 when compared with standard chow of the same genotype. **P<0.05
when compared with AlbCreþ/caNrf2 on the same diet.
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FIG. 5. Microsomal triglyceride transfer protein (MTTP) Western blot. A, Western
blot for MTTP was performed on 3 random animals from each experimental
group. B, Densitometry of the MTTP blot. Although there was no difference due
to MCD diet, there was significant increase of MTTP protein in the AlbCreþ/
caNrf2þ animals when compared with AlbCreþ/caNrf2 animals independent
of diet. *P<0.05 when compared with standard chow of the same genotype.
#P<0.05 when compared with AlbCreþ/caNrf2 on the same diet.
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Alternatively, the alterations seen in K1kd mice may result from
alterations in other pathways, since Keap1 may target other
proteins in addition to Nrf2.
The novelty of our study resides in the fact that we are the
first group to investigate the impact of cell-specific induction of
Nrf2 in NASH development using a well-characterized caNrf2
construct (Kohler et al., 2014; Schafer et al., 2012). One advantage
of our model is that it allows us to look at the effect of chronic
hepatocyte-specific Nrf2 activation on NASH development. By
using the caNrf2 construct, which leads to direct activation of
the Nrf2-ARE pathway, we can better assess the effects that are
specifically due to induction of the Nrf2-ARE pathway. This is as
opposed to the limitations of pharmacological activation, where
the extent of Nrf2 activation may be lower than in the genetic
model. In particular, Nrf2-independent effects of the com-
pounds used cannot be excluded (Aleksunes and Klaassen,
2012). In the K1kd model, Nrf2 is overexpressed via repression
of the Keap1 repressor. Although K1kd does increase Nrf2-ARE
pathway activation in all cells, it is uncertain if Keap1 plays a
role in Nrf2-independent pathways. Keap1-knock down (K1kd)
mice were initially generated due to the global Keap1-knockout
causing postnatal lethality at weaning, secondary to
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FIG. 6. F4/80 staining. Immunohistochemistry staining was performed with a-F4/80 antibody to determine the number of macrophages present as a marker of inflam-
mation. A, AlbCreþ/caNrf2 and B, AlbCreþ/caNrf2þ animals on standard chow demonstrated baseline amount of F4/80 staining. There was increased F4/80 staining
for both C, AlbCreþ/caNrf2 and D, AlbCreþ/caNrf2þ animals after 28 days of MCD diet. E, Counting the number of F4/80 positive cells demonstrated that MCD diet led
to increased inflammation in mice of both genotypes. However, there was no difference between the two genotypes on MCD diet. N¼ 6–8 for each of the 4 experimental
groups, with 4 different fields of views for each N. *P<0.05 when compared with standard chow of the same genotype. #P< 0.05 when compared with AlbCreþ/caNrf2
on the same diet.
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hyperkeratosis of the foregut leading to obstruction. Although
K1kd mice survive the weaning age, they have also been shown
to develop hyperkeratosis of their foregut, leading to poorer
feeding and lower body weight (Taguchi et al., 2010). This mal-
nutrition may lead to derangement in the metabolism of K1kd
mice globally, which can complicate the interpretation of
experiments studying NASH development using the K1kd
genetic model. Finally, it has been shown that in autophagy-
deficient mice, constitutive accumulation of Nrf2 is the
dominant cause for liver injury, and the injury is worsened with
Keap1 deficiency (Taguchi et al., 2012). However, in our model of
hepatocyte-specific Nrf2 activation using the caNrf2 construct,
we have shown that by 18 months of age, which is beyond our
experimental period, there are no demonstrable histological
abnormalities and no obvious inflammation in these livers
when compared with controls. In addition, there are no appa-
rent physiologic differences either in terms of glucose and cho-
lesterol metabolism.
Although we do see protection against hepatic steatosis by
Nrf2 activation in our model, we did not see obvious improve-
ments in terms of inflammation or oxidative stress. When
Zhang et al. (2010) investigated the effects of global Nrf2 overex-
pression with 5 days of MCD diet feeding, they demonstrated
decreased hepatic triglycerides, as well as attenuation of oxida-
tive damage and fibrosis as expected. In their study, the Nrf2-
ARE pathway was augmented globally with a 4-fold increase in
mRNA abundance and a 2-fold increase in prototypical Nrf2-
dependent proteins at baseline. This modest increase led to a
mitigation of NASH development with MCD feeding. In our
study with more prolonged feeding and Nrf2 activation in the
hepatocytes alone, we were able to generate 10- to 12-fold
increases in mRNA and protein levels of Nrf2-dependent genes
at baseline. Despite this increase, we did not see an obvious
reduction in inflammation or oxidative stress when compared
with controls. Given that Nrf2 overactivation is only present in
the hepatocytes in our model, it may be possible that Nrf2-ARE
activation in other cell types in the liver, ie, HSCs or Kupffer
cells, are required to affect these endpoints in this model of
NASH. It may be that Nrf2 overactivation in hepatocytes is not
sufficient to convey protection, or that there are certain sub-
stances in the NASH environment that neutralizes the potential
protective effects of Nrf2 overactivation in hepatocytes alone.
Upon liver injury, HSCs are activated and become myofibro-
blastic in phenotype. As a result of activation, HSCs begin to
proliferate and deposit collagen, leading to fibrosis. Since the
stellate cells have been demonstrated to express a-SMA upon
activation both in vivo and in vitro (Rockey et al., 1992), a-SMA
expression has long been a marker for stellate cell activation to
suggest subsequent fibrosis. Other published studies using
human liver tissue have demonstrated that a-SMA expression
correlates with and predicts fibrosis (Akpolat et al., 2005;
Carpino et al., 2005). Tissue inhibitor of metalloproteinase 1
(TIMP1) is expressed by activated stellate cells and contributes
TABLE 3. Expression of Genes Associated with Inflammation
Genes AlbCreþ/caNrf2 AlbCreþ/caNrf2þ Dietary Effect Genetic Effect
Std Chow MCD Std Chow MCD AlbCreþ/caNrf2 AlbCreþ/caNrf2þ Std Chow MCD
Columns 1 2 3 4 1 versus 2 3 versus 4 1 versus 3 2 versus 4
IL1B 1.006 0.25 0.6160.09 1.366 0.52 0.5460.08 — — — —
IL6 1.006 0.46 0.8460.18 0.736 0.27 0.7460.13 — — — —
IL12B 1.006 0.43 8.1360.88* 5.216 2.10 5.6361.26 8.13 — — —
TNF 1.006 0.13 0.7160.12 0.826 0.12 0.5460.10 — — — —
ICAM1 1.006 0.22 0.5860.09 0.646 0.11 0.8860.19 — — — —
CCL2 1.006 0.10 8.6161.79* 1.786 0.41 7.1861.05* 8.61 4.03 — —
CXCL10 1.006 0.13 2.6660.73 1.246 0.25 1.6160.27 — — — —
qRT-PCR was performed for genes associated with inflammation using RNAs from AlbCreþ/caNrf2 versus AlbCreþ/caNrf2þ animals on MCD diet after 28 days. The
mRNA levels are first normalized to the b-actin mRNA content of each sample, and each experimental group is then normalized to the AlbCreþ/caNrf2, standard
chow group. All data are presented as mean6SEM. N¼ 6–8 for each of the 4 groups. The fold changes in mRNA abundance were compared between groups using one-
way ANOVA with Fisher’s LSD post hoc test. Significant fold changes are presented on the right side of the table. *P<0.05 when compared with standard chow of the
same genotype. **P< 0.05 when compared with AlbCreþ/caNrf2 on the same diet.
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FIG. 7. Oxidative stress. The amounts of (A) thiobarbituric acid reactive substan-
ces (TBARS) and (B) 8-isoprostane in the liver tissues collected were measured as
markers for oxidative stress. MCD diet led to increased oxidative stress in mice
of both genotypes, but there was no difference between the AlbCreþ/caNrf2
and the AlbCreþ/caNrf2þ animals on MCD diet. N¼6–8 for each of the 4 groups.
*P<0.05 when compared with standard chow of the same genotype. #P<0.05
when compared with AlbCreþ/caNrf2 on the same diet.
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to the development of fibrosis by preventing degradation of col-
lagen and other matrix proteins. Increased TIMP1 message
expression has shown to be increased in fibrotic human livers
when compared with normal human livers (Benyon et al., 1996).
In our study, we saw increases in a-SMA expression and TIMP1
gene expression as a result of the MCD diet, suggesting HSC
activation. However, among the animals that received MCD
diet, we did not see changes between the genotypes, suggesting
there are no changes in terms of fibrogenic potential.
Interestingly, we did not see any increases in collagen mRNA as
a result of diet, which may be due to the relative early time
point of our experiment when the actual collagen deposition of
the fibrosis process has yet to set in. Thus, although long-term
Nrf2 activation in hepatocytes alone is enough for protection
against steatosis, it is not sufficient to provide protection
against oxidative stress and the early development of fibrosis in
our model. Thus, it is possible that Nrf2 induction in the non-
parenchymal cell population is required for further protection
against NASH development.
To better understand how cell-specific activation of the
Nrf2-ARE pathway in hepatocytes leads to a decrease in steato-
sis, we examined the fatty acid metabolism genetic expression
profile for our transgenic animals on MCD diet. When we com-
pared AlbCreþ/caNrf2þ with AlbCreþ/caNrf2 animals on MCD
diet, we did not see any genotype-dependent alterations in the
major lipid metabolism regulator genes tested, including LXR,
PPARa, PPARc, and SREBF1. This is contrary to previous studies
where SREBF1 mRNA was increased in Nrf2 KO mice on HFD
(Okada et al., 2013; Tanaka et al., 2008). Previous studies have
also suggested PPARc mRNA to be affected by changes in Nrf2
expression. However, the findings have been inconsistent:
Sugimoto et al. (2010) showed that PPARc increased in Nrf2 KO
mice on MCD diet, and this was associated with increased stea-
tosis; yet, Tanaka et al. (2008) showed that PPARc decreased in
Nrf2 KO mice on HFD, and this was also associated with wors-
ened steatosis; finally, More et al. (2013) showed that PPARc
increased in K1Kd mice on HFD, and this was associated with
worsened steatosis. Given that we were not able to detect any
differences in the lipid regulators in our study, we suspect that
changes in the expression of individual lipid metabolism genes
may be directly due to changes in Nrf2 expression.
We did see significant changes in the gene expression of
MTTP and CPT2 between AlbCreþ/caNrf2 and AlbCreþ/
caNrf2þ animals on MCD diet. Microsomal triglyceride transfer
protein, or MTTP, is a protein that is important in the assembly
of VLDL, which is important for export of triglyceride from
hepatocytes (Blasiole et al., 2007; Wang et al., 1997). In our study,
we found that while MCD diet reduced MTTP mRNA in mice of
both genotypes, this reduction in AlbCreþ/caNrf2þ animals was
significantly less than the reduction in AlbCreþ/caNrf2 ani-
mals. This results in a relative increase in the expression of
MTTP mRNA in the AlbCreþ/caNrf2þ animals on MCD diet. On
the protein level, we observed an increase in MTTP in AlbCreþ/
caNrf2þ animals regardless of diet type when compared with
the AlbCreþ/caNrf2 animals. The discrepancy we see between
the decrease in gene expression and increase in protein expres-
sion may be due to prolonged MCD diet stimulation, leading to
increased protein expression with negative regulation of the
gene expression. In another study by Tanaka et al. (2008), they
found decreased MTTP mRNA in the Nrf2 KO animals at base-
line, and a further decrease in the Nrf2 KO animals on HFD diet.
These findings together suggest that MTTP may be a potential
Nrf2-dependent mechanism of protection against steatosis.
Given this, we expected the serum triglycerides to be signifi-
cantly elevated in the AlbCreþ/caNrf2þ animals receiving MCD
diet. Instead, we saw no differences in the serum triglycerides
among all the experimental groups. This may be due to
increased peripheral uptake of triglycerides in adipose tissue.
Unfortunately, based on our study design, we were unable to
assess this potential mechanism of serum triglyceride level
modulation.
We also looked into the expression of genes related to b-oxi-
dation, notably CPT1A and CPT2. CPT codes for carnitine palmi-
toyltransferase, which is an essential enzyme for fatty acid
b-oxidation. Although CPT1A is the liver isoform located on the
outer mitochondrial membrane, CPT2 is located on the inner
mitochondrial membrane. In our study, we saw decreased
CPT1A at baseline with Nrf2 overactivation. Although there
appeared to be a trend toward increase in CPT1A expression in
the AlbCreþ/caNrf2þ when fed a MCD diet when compared with
AlbCreþ/caNrf2 mice on MCD diet, it was not statistically sig-
nificant. On the other hand, the gene expression of CPT2
behaved similarly as MTTP. Although there was no difference at
baseline, CPT2 was decreased in mice of both genotypes when
subjected to MCD diet. However, in the animals with Nrf2 over-
activation, the extent of decrease was significantly less than in
the control animals. This relative increase in b-oxidation gene
expression may be contributing to the decreased steatosis that
is seen in AlbCreþ/caNrf2þ animals on MCD diet.
Although not many published studies have looked at the
expression of CPT2, some studies have looked at the gene
expression of CPT1. In comparing WT to Nrf2 KO animals at
TABLE 4. Expression of Genes Associated with Fibrosis
Genes AlbCreþ/caNrf2 AlbCreþ/caNrf2þ Dietary Effect Genetic Effect
Std Chow MCD Std Chow MCD AlbCreþ/caNrf2- AlbCreþ/caNrf2þ Std Chow MCD
Columns 1 2 3 4 1 versus 2 3 versus 4 1 versus 3 2 versus 4
COL1A1 1.0060.11 0.806 0.11 1.456 0.29 1.136 0.22 — — — —
TIMP1 1.0060.09 5.256 0.82* 1.756 0.50 3.746 0.53* 5.25 2.14 — —
TIMP2 1.0060.08 1.056 0.12 1.126 0.13 1.036 0.09 — — — —
MMP2 1.0060.14 0.996 0.11 1.396 0.10 1.266 0.20 — — — —
MMP9 1.0060.09 0.916 0.09 1.276 0.28 0.966 0.11 — — — —
qRT-PCR was performed for genes associated with fibrosis using RNAs from AlbCreþ/caNrf2 versus AlbCreþ/caNrf2þ animals on MCD diet after 28 days. The mRNA
levels are first normalized to the b-actin mRNA content of each sample, and each experimental group is then normalized to the AlbCreþ/caNrf2, standard chow
group. All data are presented as mean6SEM. N¼6–8 for each of the 4 groups. The fold changes in mRNA abundance were compared between groups using one-way
ANOVA with Fisher’s LSD post hoc test. Significant fold changes are presented on the right side of the table. *P<0.05 when compared with standard chow of the same
genotype. **P< 0.05 when compared with AlbCreþ/caNrf2 on the same diet.
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baseline, Tanaka et al. (2012) showed increased CPT1 in the Nrf2
KO animals, consistent with our CPT1A finding. However, when
the mice were fed their NASH inducing diet, which is a combi-
nation of HFD with carbonyl iron, Tanaka et al. demonstrated
that Nrf2 KO animals have significantly decreased CPT1 expres-
sion when compared with WT animals, suggesting decreased
b-oxidation gene expression in the Nrf2 KO animals under
stress. Our findings in combination with other published data
suggest that Nrf2 may affect b-oxidation via changes in the
expression of CPTs.
CONCLUSION
In this study, we utilized transgenic mice with hepatocyte-spe-
cific expression of a constitutively active Nrf2 mutant (Kohler
et al., 2014) to study its impact on NASH development using
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FIG. 8. Hepatic stellate cell activation. Immunohistochemistry was performed with an a-SMA antibody to determine stellate cell activation. There appeared to be
minimal a-SMA staining in both (A) AlbCreþ/caNrf2 and (B) AlbCreþ/caNrf2þ animals on standard chow. There was increased a-SMA staining for both (C)
AlbCreþ/caNrf2 and (D) AlbCreþ/caNrf2þ animals after 28 days of MCD diet. E, Western blot of a-SMA was performed on 3 random animals of each experimental
group. F, Densitometry of the Western blot demonstrated that MCD diet led to increased HSC activation for both genotypes. However, there was no difference between
the two genotypes on MCD diet. *P<0.05 when compared with standard chow of the same genotype. #P< 0.05 when compared with AlbCreþ/caNrf2 on the same diet.
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MCD diet. We found that hepatocyte-specific activation of the
Nrf2-ARE pathway leads to decreased hepatic steatosis and
decreased hepatocellular damage without affecting other
aspects of NASH development including inflammation, oxida-
tive stress, or HSC activation. Although the Nrf2-ARE pathway is
a key antioxidant pathway, the overexpression of Nrf2 target
genes in hepatocytes alone did not alter the degree of oxidative
stress within the liver in our model. We suspect that induction
of Nrf2 in non-parenchymal cells in the liver may be critical in
decreasing oxidative stress, inflammation, and HSC activation
that are seen with NASH generated by MCD diet.
In addition, the reduction of hepatic steatosis was associated
with increased expression of genes involved in triglyceride
export (MTTP) and b-oxidation of fatty acids (CPT2). The changes
in these lipid metabolic genes raise the possibility for novel
roles of Nrf2 in lipid metabolism. Further experiments would be
required to elucidate the mechanistic role of Nrf2 in lipid
metabolism.
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